PMID: 29364588
Pharmacological effects and clinical applications of propionyl-L-carnitine
When focusing specifically on GLP-1 use among patients with an obesity diagnosis, there is an even larger disparity between states, with rates ranging from 14.8% in Alaska to just 2.3% in Arizona
Concurrently, it is also necessary to determine the optimal dosage, duration, and frequency of probiotic and prebiotic administration
Counterfeit GLP-1 drugs have become, as Katherine Eban wrote in a Vanity Fair investigation, a hot commodity among transnational crime groups, homegrown counterfeiters, rogue compounders, shady middlemen, unscrupulous doctors, and medi-spas of dubious legality. By February, Eban reported, illegal pharmacies in the US were filling more than 734,000 GLP-1 prescriptions per month, according to data compiled by Translucent DataLab, which scrutinizes illegal online pharmacies, and IQVIA, a major data and clinical research company